drugset / Trial / NCT05253014

Different Approaches for the Management of Post-dural Puncture Headache

NCT05253014 ↗

Completed 120 enrolled Bahaa Mohammed Refaie
RandomizedParallel-groupTriple-blindTreatment

Summary

Detecting the efficacy and safety of trans-nasal sphenopalatine ganglion block using either lidocaine 2% or bupivacaine 0.5 % as a treatment line for post-dural puncture headache

Timeline

Start
2018-01-01
Primary completion
2020-10-30
Completion
2020-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule — Intravenous